Srikem Laboratories is an API manufacturer based in United States. It holds 3 active US drug master files across a filed portfolio of 4 molecules. Customs aggregates show $4.7M of exports covering 257 molecules to 31 destinations in 2025.
| Molecule | Regulators | Docs |
|---|---|---|
| Hydroxyzine | US FDA | 1 |
| Meclizine | US FDA | 1 |
| Permethrin | US FDA | 1 |
| Silver Sulfadiazine | SFDA (Saudi Arabia) | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 1 | None |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $649K | 12 |
| 2025 | Not reported | $4.7M | 31 |
| 2024 | Not reported | $7.0M | 29 |
| 2023 | Not reported | $8.0M | 28 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Choose your molecules and target markets. Srikem Laboratories comes back tiered against every other supplier able to file there.
Start for free